Hla

• The Human Leukocyte Antigen (HLA) system identifies self from non-self, crucial for immune defense.
• HLA genes are highly diverse, influencing individual immune responses and susceptibility to various diseases.
• HLA typing is essential for assessing compatibility in transplantation to prevent rejection.
• The unique combination of HLA types in each person makes finding compatible donors challenging.

What is HLA (Human Leukocyte Antigen) and Its Function?

The Human Leukocyte Antigen (HLA) system is a complex group of genes located on chromosome 6 that encode proteins found on the surface of most cells in the body. These proteins, also known as major histocompatibility complex (MHC) molecules in other species, play a pivotal role in the immune system’s ability to recognize and respond to foreign substances. Essentially, the HLA system functions as the body’s identification tag, allowing immune cells to differentiate between healthy self-cells and potentially harmful foreign cells or infected self-cells.

The primary function of the HLA system is antigen presentation. HLA molecules bind to fragments of proteins (peptides) from within the cell and display them on the cell surface. T-cells, a type of white blood cell, then inspect these presented peptides. If a T-cell recognizes a peptide as foreign (e.g., from a virus or bacteria), it triggers an immune response to eliminate the threat. This intricate mechanism is vital for protecting the body from pathogens and abnormal cells, such as cancer cells.

HLA Genes: Importance in Immunity and Disease

The genes encoding HLA molecules are among the most polymorphic in the human genome, meaning there are many different versions (alleles) of these genes within the population. This extraordinary diversity ensures that a wide range of foreign antigens can be recognized, providing a robust defense against evolving pathogens. The specific combination of HLA genes and their importance is profound, as they dictate an individual’s unique immune fingerprint.

This genetic variation also has significant implications for disease. Certain HLA alleles are associated with an increased susceptibility or resistance to various conditions, including autoimmune diseases like type 1 diabetes, rheumatoid arthritis, and celiac disease. For instance, specific HLA-DQ alleles are strongly linked to an increased risk of celiac disease, affecting approximately 1 in 100 people globally, according to the Celiac Disease Foundation. Furthermore, HLA genes influence the body’s response to infectious agents and even the efficacy of certain vaccines and drug therapies.

Understanding HLA Types and Compatibility

Understanding HLA types and compatibility is crucial, particularly in the context of organ and stem cell transplantation. Each person inherits a set of HLA genes from each parent, resulting in a unique HLA profile. When a patient requires a transplant, medical professionals perform HLA typing to identify the specific HLA alleles present in both the recipient and potential donors. The goal is to find the closest possible match to minimize the risk of transplant rejection.

Transplant rejection occurs when the recipient’s immune system recognizes the donor’s HLA molecules as foreign and mounts an attack against the transplanted organ or cells. A close HLA match significantly improves the chances of a successful transplant and reduces the need for heavy immunosuppressive medications, which can have severe side effects. The major HLA classes considered for compatibility are:

• HLA Class I: Found on almost all nucleated cells, presenting peptides from inside the cell. Key types include HLA-A, HLA-B, and HLA-C.
• HLA Class II: Primarily found on antigen-presenting cells (e.g., dendritic cells, macrophages, B cells), presenting peptides from outside the cell. Key types include HLA-DR, HLA-DQ, and HLA-DP.

Due to the vast diversity of HLA alleles, finding a perfectly matched unrelated donor can be challenging. For example, the probability of finding a match for a bone marrow transplant can be as low as 1 in 100,000 or even lower for individuals from ethnic minorities, highlighting the critical need for diverse donor registries worldwide.